Publication & Citation Trends
Publications
0 total
Abstract A020-PR004: KAT6A and KAT6B are therapeutic targets to enhance the efficacy of differentiation therapy and GD2 immunotherapy in neuroblastoma
Cited by 0
Semantic Scholar
Abstract 2601: KAT6A and B inhibition increases efficacy of differentiation and GD2 targeting immunotherapy in neuroblastoma
Cited by 0
Semantic Scholar
Multitargeted Reduction of Inflammation and Atherosclerosis in Tet2-deficient CHIP via XPO1 Inhibition and Atf3 restoration
Cited by 1
Semantic Scholar
KAT6A/B inhibition synergizes with retinoic acid and enhances the efficacy of GD2-targeted immunotherapy in neuroblastoma
Cited by 0
Semantic Scholar
Accurate Measurement of Cell Number–Normalized Differential Gene Expression in Cells Treated With Retinoic Acid
Cited by 0
Semantic Scholar
Abstract 2852: Novel combination therapy with a KAT6A/B inhibitor together with retinoids induces irreversible differentiation of neuroblastoma cells
Cited by 0
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(26)
Immune Cell Function and Interaction
(24)
CAR-T cell therapy research
(20)
T-cell and B-cell Immunology
(11)
interferon and immune responses
(9)
Affiliations
Ontario Institute for Cancer Research
Brigham and Women's Hospital
Boston Children's Hospital
Harvard University
University of Toronto